AI assistant
ADVERITAS LIMITED — Director's Dealing 2021
Oct 7, 2021
64465_rns_2021-10-07_10e4c484-0d28-4989-8ce5-b5705e0f31f5.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ADVERITAS LIMITED ABN 88 156 377 141
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Stephen Frank Belben
Date of last notice 22 September 2020
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | SF Belben & PJ Belben <Belben SuperFund A/C>- trustee and beneficiary ofaccount. |
| Date of change | 7 October 2021 |
| No. of securities held prior to change | SF Belben & PJ Belben <Belben SuperFund A/C>720,000 Fully paid ordinary shares.90,000 quoted options exercisable at $0.10on or before 25/10/2021.SF Belben <Belben Family A/C>750,000 unquoted options exercisable at$0.20, expiring 27/3/2022.1,250,000 unquoted options exercisable at$0.15, expiring 3/7/2023. |
| Class | Fully paid ordinary shares.Quoted options exercisable at $0.10 on orbefore 25/10/2021. |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | 90,000 fully paid ordinary shares. |
|---|---|
| Number disposed | 90,000 quoted options exercisable at $0.10on or before 25/10/2021. |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | $0.10 each |
| No. of securities held after change | SF Belben & PJ Belben <Belben SuperFund A/C>810,000 Fully paid ordinary shares.SF Belben <Belben Family A/C>750,000 unquoted options exercisable at$0.20, expiring 27/3/2022.1,250,000 unquoted options exercisable at$0.15, expiring 3/7/2023. |
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back | Exerciseof90,000quotedoptionsexercisableat$0.10onorbefore25/10/2021 into 90,000 fully paid ordinaryshares. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder(if issued securities) | |
| Date of change | |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | |
| Interest acquired | |
| Interest disposed |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed | No |
| above traded during a+closed period where prior written | |
| clearance was required? | |
| If so, was prior written clearance provided to allow the trade | N/A |
| to proceed during this period? | |
| If prior written clearance was provided, on what date was this | N/A |
| provided? |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3